AIAI Holdings Corporation (AIAI): Rochon Family Buys ~$26.8M in Shares

AIAI Holdings (NASDAQ:AIAI) announced its affiliate, Messier 42 LLC, will contribute a controlling position in a marketing agreement for military equipment sales. The deal, requiring no cash or stock consideration, is expected to close in October 2026 and generate $250 million in free cash flow over 12 months, with 50% distributed to M42. The transaction replaces a previous acquisition plan.

AIAI Holdings (NASDAQ:AIAI) has signed a letter of intent to acquire a controlling stake in a defense company from Messier 42 LLC. The target is projected to generate $250M in free cash flow annually post-closing. The deal, expected to close in Q4 2026, is subject to due diligence, board approvals, and a fairness opinion.

AIAI Holdings said its portfolio company Constellation Network will launch Constellation Gate AI, an AI security and audit gateway, in June 2026. Constellation’s technical report evaluated prompt-injection defenses across 16 public datasets, reporting an F1 of 97.4% at a 1% false-positive rate and top rankings on 8 datasets. It also cited median response time of 53 ms.

AIAI Holdings said its portfolio company Constellation Network will launch Constellation Gate AI in June 2026. A technical report, according to Constellation, found Gate AI ranked first on 8 of 16 public prompt-injection benchmark datasets and top three on 4 more, with an F1 of 97.4% at a 1% false-positive rate and median response time of 53 ms.

BTIG kept its Buy rating on Avalo Therapeutics with a $10.00 price target, suggesting a 34.2% upside from the Oct 22 close. The firm cited strong Phase 2 trial results for lead asset Abdakibart, favorable safety profile, and market opportunity in hidradenitis suppurativa.

BNP Paribas raised its price target for Lockheed Martin (LMT) to $670 from $560, while Barclays adjusted its target to $560 from $554. The stock has seen a 5-day increase of 6.96% and a year-to-date gain of 21.97%.